Market Place
Sourcing Support
BMS pays $65M to expand Repertoire of autoimmune assets
30 Apr 2024 //
FIERCE BIOTECH
Repertoire®, BMS Collaborate on Tolerizing Vaccines for Autoimmunity
29 Apr 2024 //
PR NEWSWIRE
Repertoire® Immune Medicines Presents New Data From Its DECODE™ Platform
10 Nov 2022 //
BUSINESSWIRE
Torben Straight Nissen Joins Repertoire Immune Medicines as CEO
07 Nov 2022 //
BUSINESSWIRE
UPDATE: Flagship`s Repertoire reveals culls, cuts and new CEO
07 Nov 2022 //
FIERCEBIOTECH
Scoop: Flagship-founded Repertoire cuts 45% of its staff
04 Nov 2022 //
FIERCEBIOTECH
New Data From Repertoire Demonstrate Effectiveness of Its DECODE Platform
05 Oct 2022 //
BUSINESSWIRE
Preclinical Research Published in Science Advances on Repertoire Immune Medicine
27 Apr 2022 //
BUSINESSWIRE
RIM’s Provided Characterization of CD8+ T Cell Responses to SARS-CoV-2
18 Nov 2021 //
BUSINESSWIRE
Repertoire Begins Dosing in Phase 1 Study of RPTR-168
11 Oct 2021 //
BUSINESSWIRE
Cybin Advances IND-Enabling Studies of Two Psychedelic Molecules, CYB003
13 Apr 2021 //
BUSINESSWIRE
Repertoire Immune Medicines to Present Data from Autologous T Cell Therapy
09 Apr 2021 //
BUSINESSWIRE
Repertoire Immune Medicines Pre-publishes New Research Identifying
03 Mar 2021 //
BUSINESSWIRE
Repertoire Immune Medicines Presents First Data on PRIME IL-15 Cell Therapy
09 Nov 2020 //
BIOSPACE
Chutes & Ladders—Day One brings on Gilead alum Bender as CEO
25 Sep 2020 //
FIERCE BIOTECH
Flagship`s merged biotech Repertoire nets ex-Pfizer CSO A. Coyle as R&Dchief
22 Sep 2020 //
ENDPTS
Flagship Pioneering`s 2-becomes-one biotech nabs ex-Pfizer CSO as research lead
21 Sep 2020 //
FIERCE BIOTECH
Repertoire Immune Medicines Receives Funding From COVID-19
24 Jun 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.